Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00127790
Status:
COMPLETED
Last Update Posted:
2012-10-17
First Post:
2005-08-03
Brief Title:
Treatment of Insomnia Secondary to Chronic Pain
Sponsor:
University of Rochester
Organization:
University of Rochester
Study Overview
Official Title:
CBT for Co-Morbid Insomnia and Chronic Pain Sleep Pain and Immune Function Outcomes
Status:
COMPLETED
Status Verified Date:
2012-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Several studies have shown that behavioral therapy for chronic pain can be beneficial for chronic pain and that behavioral therapy for insomnia can be beneficial for insomnia However seldom do chronic pain patients with insomnia receive a behavioral treatment for insomnia The purpose of this study is to evaluate whether treatment for insomnia is helpful for pain and whether treatment for pain is helpful for insomnia It will also assess whether a combined treatment is any more or less effective for pain or for sleep Finally the study will assess whether any of these treatments leads to improvements in immune function
Detailed Description:
The investigators primary goal is to assess the extent to which three forms of cognitive-behavioral treatment CBT for insomnia CBT for pain and combined insomnia pain diminishes insomnia symptoms in patients with chronic pain compared to a group not receiving CBT This will be evaluated in a randomized trial with before and after evaluations using standard sleep diary measures of sleep continuity
The investigators secondary goal is to assess whether treatment responses to any of the interventions are associated with alterations in immune function
The investigators tertiary goals are to evaluate whether improved sleep has effects on patient reports of pain severity frequency and tolerability as well as on mood and quality of life
The investigators secondary goal is to assess whether treatment responses to any of the interventions are associated with alterations in immune function
The investigators tertiary goals are to evaluate whether improved sleep has effects on patient reports of pain severity frequency and tolerability as well as on mood and quality of life
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R21AG023956 | NIH | Rochester Center for MindBody Research | httpsreporternihgovquickSearchR21AG023956 |
| K23NR010408 | NIH | None | None |
| R21AG023956 R24AG031089 | OTHER | None | None |
| F32NS049789 | NIH | None | None |